1. Stats
  2. USPTO
  3. TC 3900
  4. Group 3990
  5. Art Unit 3991
  6. Examiner Kosack

Examiner Kosack Joseph R

3991-KOSACK-JOSEPH-R

Employment Information

Art Unit:3991 — Active solid-state devices (e.g., transistors, solid-state diodes)
Group:3990 — Central Reexamination Unit
Classes: 514 — Drug, bio-affecting and body treating compositions
548 — Organic compounds -- part of the class 532-570 series
558 — Organic compounds -- part of the class 532-570 series
534 — Organic compounds -- part of the class 532-570 series
544 — Organic compounds -- part of the class 532-570 series
546 — Organic compounds -- part of the class 532-570 series
549 — Organic compounds -- part of the class 532-570 series
424 — Drug, bio-affecting and body treating compositions
257 — Active solid-state devices (e.g., transistors, solid-state diodes)
428 — Stock material or miscellaneous articles
Phone:(571) 272-5575
Email:joseph.kosack@uspto.gov
Location:VA 22314

Grant Rate and Difficulty Ranking

45
3-Year Grant rate: 80% over 561 cases
Difficulty: Medium
Difficulty Percentile: 45th

With Examiner Kosack, you have a 80% chance of getting an issued patent by 3 years after the first office action. Examiner Kosack is a medium examiner and in the 45th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Kosack, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 3991

Examiner Kosack's grant rate is higher than that of Art Unit 3991 and higher than that of the USPTO.

Average Office Actions Per Grant
Examiner Kosack 1.1
Art Unit 3991 1.8

Interview Benefit

Grant Rate without Interview

Examiner Kosack has granted 424 of 530 cases without any applicant-requested interviews for a grant rate of 80%.

Grant Rate with Interview

Examiner Kosack has granted 25 of 31 cases with at least one applicant-requested interview for a grant rate of 81%.

Interview Benefit

With Examiner Kosack, conducting an interview increases your chance of getting a patent granted by 1%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
17903659 Pro-Fragrance Compounds Rejection information available with a Premium Stats subscription. See our pricing. Patented View
18515978 Thickener Composition, Thickened Nutritive Products, Methods For Preparing Thickened Nutritive Products, And Methods For Providing Nutrition Patented View
18198430 Polymer Composition Patented View
18212692 Benzamide Compounds Patented View
17896658 Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer Patented View
18310320 Artificial Nail Tip And Curing Composition Set And Applying Method Thereof Patented View
18137307 Cyclodextrin Derivatives In The Treatment Or Prevention Of Lysosomal Neurodegenerative Diseases Patented View
17880134 Psilocybin And/or Psilocin In Combination With Cannabinoids And/or Terpenes Abandoned View
18087665 Ultra High Molecular Weight Polyethylene Multifilament Yarn Patented View
17524503 Cat Litter Product Patented View
17822611 Method Of Treatment With Tradipitant Abandoned View
17581586 Prodrug Salts Of 2, 4-Pyrimidinediamine Compounds And Their Uses Abandoned View
17571911 Herbicidal Composition Patented View
17817306 High Protein, Fruit Flavoured Beverage; High Protein, Fruit And Vegetable Preparation; And Related Methods And Food Products Patented View
18295133 Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, And Methods Of Use Thereof Patented View
18501647 Process For Preparing Btk Inhibitors Patented View
18159452 Isoindolinone Inhibitors Of The Mdm2-P53 Interaction And Process For Making Them Patented View
18194410 Compositions And Methods For Treating Cancer Patented View
17296695 Preparation Of Sulfonamide Herbicide Process Intermediates Patented View
17425038 Production Processes Of S- And O-Diacylated Gamma-Glutamyl-Cysteamine Prodrugs Patented View
16999818 Strongly Lewis Acidic Metal-Organic Frameworks For Continuous Flow Catalysis Patented View
18544286 Reversible Photoswitchable Isomerization Of Novel Sterically Hindered 2,2',6,6'-Tetramethyl-4,4'-Bis((Trimethylsilyl)ethynyl)azobenzene Patented View
17937106 Pyrazoloquinoline Kras Inhibitors Patented View
18174832 Pyrazole Derivatives Useful As 5-Lipoxygenase Activating Protein (Flap) Inhibitors Patented View
18059516 Polynitroso Compound, Its Preparation And Electrochemical Use Patented View
17104166 Compositions And Methods For Chemical Synthesis Patented View
17332100 Metal-Assisted Delayed Fluorescent Emitters Employing Benzo-Imidazo-Phenanthridine And Analogues Patented View
17470980 Fused Piperidinyl Bicyclic And Related Compounds As Modulators Of C5a Receptor Patented View
17264333 Crystalline Forms Of A Lta4h Inhibitor Patented View
18401918 Polyelectrochromism Of Electronically Weakly Coupled 4,4'-Divinylazoarylene-Bridged Two Ru(Co)cl(Pipr3)2 Entities Patented View
18095051 Silyl Phosphine Compound, Process For Producing Silyl Phosphine Compound And Process For Producing Inp Quantum Dots Abandoned View
17340658 Multi-Functionalized Hollow Fiber Organocatalysts Abandoned View
17931843 Bi-Functional Compounds And Methods For Targeted Ubiquitination Of Androgen Receptor Patented View
17752201 Method Of The Isolating Chlorosesamone Or Chlorosesamone-Containing Fraction From Roots Of Genus Sesamum, And Application Of The Fraction Thereof Abandoned View
17156526 Process For The Preparation Of Highly Pure Erlotinib Hydrochloride Abandoned View
18383754 4-((5-(3-Fluorophenyl)-4-Phenyl-4h-1,2,4-Triazol-3-Ylthio)methyl)benzoic Acid As An Antimicrobial Compound Patented View
17860873 Multifunctional Conjugates Patented View
17515910 Reactions Of Olefin Derivatives In The Presence Of Methathesis Catalysts Patented View
17256785 Composition For Inhibiting Fat Accumulation Abandoned View
16956325 Process For Preparing A Copolyamide Without Encrustation In The Autoclave Abandoned View
17138578 Process For Recovering Adiponitrile Abandoned View
18384982 4,4'-Naphthalene-1,5-Diylbis(Diazene-2,1-Diyl)bis(2-Methylphenol)as An Antioxidant Compound Patented View
17314079 Acetonitrile Purification Process For Ultrahigh Performance Liquid Chromatography-Mass Spectrometer Patented View
17723313 Treatment Of Tinnitus Using Glutamate Receptor Agonists Patented View
17517846 1,7-Diaryl-1,6-Heptadiene-3,5-Dione Derivatives, Methods For The Production And Use Thereof Patented View
18080861 Palladium Precatalyst For Cross-Coupling Reaction And Synthesis Method Thereof Patented View
17271479 Heterocyclic Compound Patented View
16903645 Modified Antibodies And Related Compounds, Compositions And Methods Of Use Patented View
18252821 Compound And Method For Producing Same Patented View
17983474 Spiropyrrolidine Derived Antiviral Agents Patented View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.